UBS raised the firm’s price target on Xometry (XMTR) to $35 from $33 and keeps a Neutral rating on the shares. Demand remained strong in Q1 and the company raised its 2025 revenue outlook, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on XMTR: